Role of long-term potentiation of sympathetic ganglia (gLTP) in hypertension

Clinical and Experimental Hypertension

Volumn 29, Issue 5, 2007, Pages 267-286

  Alkadhi, Karim ^a   Alzoubi, Karem ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Aged rat; Morphine; Naloxone; Obese rat; Psychosocial stress; SHR; Zucker rat

Indexed keywords

MORPHINE; NALOXONE; NICOTINIC RECEPTOR; OUABAIN; SEROTONIN 3 AGONIST;

AGING; ATHEROSCLEROSIS; AUTONOMIC GANGLION; BLOOD PRESSURE MEASUREMENT; BRAIN STEM; CARDIOVASCULAR FUNCTION; CHRONIC STRESS; ELECTROPHYSIOLOGY; HYPERTENSION; LONG TERM POTENTIATION; MENTAL STRESS; NEUROTRANSMISSION; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC GANGLION; SYNAPTIC TRANSMISSION;

AGING; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; GANGLIA, SYMPATHETIC; HUMANS; HYPERTENSION; LONG-TERM POTENTIATION; OBESITY; OUABAIN; RATS; RATS, INBRED SHR; RATS, ZUCKER; RECEPTORS, SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 34547177458     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701500356     Document Type: Review

References (139)

1. Volle RL. Enhancement of neuromuscular responses to acetylcholine and succinylcholine following repetitive stimulation of the motor nerve. Arch Int Pharmacodyn Ther. 1966;160: 284-293.
2. Dunant Y, Dolivo M. Plasticity of synaptic functions in the exised sympathetic ganglion of the rat. Brain Res. 1968;10:271-273.
3. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232: 331-356.
4. Brown TH, McAfee DA. Long-term synaptic potentiation in the superior cervical ganglion. Science. 1982;215:1411-1413.
5. Briggs CA, Brown TH, McAfee DA. Neurophysiology and pharmacology of long-term potentiation in the rat sympathetic ganglion. J Physiol. 1985;359:503-521.
6. Briggs CA, McAfee DA, McCaman RE. Long-term potentiation of synaptic acetylcholine release in the superior cervical ganglion of the rat. J Physiol. 1985;363:181-190.
7. Koyano K, Kuba K, Minota, S. Long-term potentiation of transmitter release induced by repetitive presynaptic activities in bull-frog sympathetic ganglia. J Physiol 1985;359:219-233.
8. Briggs CA, McAfee DA. Long-term potentiation at nicotinic synapses in the rat superior cervical ganglion. J Physiol. 1988;404:129-144.
9. Briggs CA, McAfee DA, McCaman RE. Long-term regulation of synaptic acetylcholine release and nicotinic transmission: the role of cyclic AMP. Br J Pharmacol. 1988;93:399-411.
10. Alonso-deFlorida F, Morales MA, Minzoni AA. Modulated long-term potentiation in the cat superior cervical ganglion in vivo. Brain Res. 1991;544:203-210.
11. Bachoo M, Polosa C. Preganglionic axons from the third thoracic spinal segment fail to induce long-term potentiation in the superior cervical ganglion of the cat. Can J Physiol Pharmacol. 1992;70(Suppl.):S27-S31.
12. Weinreich D, Undem BJ, Taylor G, Barry MF. Antigen-induced long-term potentiation of nicotinic synaptic transmission in the superior cervical ganglion of the guinea pig. J Neurophysiol. 1995;73:2004-2016.
13. Alkadhi KA, Salgado-Commissariat D, Hogan YH, Akpaudo SB. Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors. J Physiol. 1996;496(Pt 2):479-489.
14. Scott TR, Bennett MR. The effect of ions and second messengers on long-term potentiation of chemical transmission in avian ciliary ganglia. Br J Pharmacol. 1993;110:461-469.
15. Hadjiconstantinou M, Potter PE, Neff NH. Trans-synaptic modulation via muscarinic receptors of serotonin-containing small intensely fluorescent cells of superior cervical ganglion. J Neurosci. 1982;2:1836-1839.
16. Eranko L, Paivarinta H, Soinila S, Happola O. Transmitters and modulators in the superior cervical ganglion of the rat. Med Biol. 1986;64:75-83.
17. Case CP, Matthews MR. Incoming synapses and size of small granule-containing cells in a rat sympathetic ganglion after post-ganglionic axotomy. J Physiol. 1986 May;374:33-71.
18. Martin AR, Pilar G. Presynaptic and post-synaptic events during post-tetanic potentiation and facilitation in the avian ciliary ganglion. J Physiol. 1964;175:17-30.
19. Magleby KL, Zengel JE. A quantitative description of tetanic and post-tetanic potentiation of transmitter release at the frog neuromuscular junction. J Physiol. 1975;245: 183-208.
20. Bennett MR. Nitric oxide release and long term potentiation at synapses in autonomic ganglia. Gen Pharmacol. 1994;25:1541-1551.
21. Lin YQ, Bennett MR. Nitric oxide modulation of quantal secretion in chick ciliary ganglia. J Physiol. 1994;481(Pt. 2):385-394.
22. Brain KL, Bennett MR. Calcium in the nerve terminals of chick ciliary ganglia during facilitation, augmentation and potentiation. J Physiol. 1995;489(Pt 3):637-648.
23. Minota S, Kumamoto E, Kitakoga O, Kuba K. Long-term potentiation induced by a sustained rise in the intraterminal Ca2+ in bull-frog sympathetic ganglia. J Physiol. 1991;435:421-438.
24. Alkadhi KA, Altememi GF. Nitric oxide mediates long-term potentiation in rat superior cervical ganglion. Brain Res. 1997;753:315-317.
25. Alkadhi KA, Al-Hijailan RS, Malik K, Hogan YH. Retrograde carbon monoxide is required for induction of long-term potentiation in rat superior cervical ganglion. J Neurosci. 2001;21:3515-3520.
26. Alkadhi KA, Otoom SA, Tanner FL, Sockwell D, Hogan YH. Inhibition of ganglionic longterm potentiation decreases blood pressure in spontaneously hypertensive rats. Exp Biol Med (Maywood). 2001;226:1024-1030.
27. Gerges NZ, Aleisa AM, Alhaider AA, Alkadhi KA Reduction of elevated arterial blood pressure in obese Zucker rats by inhibition of ganglionic long-term potentiation. Neuropharmacology. 2002;43:1070-1076.
28. Bachoo M, Polosa, C. Long-term potentiation of nicotinic transmission by a heterosynaptic mechanism in the stellate ganglion of the cat. J. Neurophysiol. 1991;65:639-647.
29. Heppner TJ, Fiekers JF. Long-term potentiation of nicotinic synaptic transmission in rat superior cervical ganglia produced by phorbol ester and tetanic stimulation. Auton Neurosci. 2003;105:35-44.
30. Morales MA, Bachoo M, Collier B, Polosa C. Pre- and postsynaptic components of nicotinic long-term potentiation in the superior cervical ganglion of the cat. J Neurophysiol. 1994;72:819-824.
31. Cavalcante de Albuquerque AA, Leal-Cardoso JH, Weinreich D. Antigen-induced synaptic plasticity in sympathetic ganglia from actively and passively sensitized guinea-pigs. J Auton Nerv Syst. 1996;61:139-144.
32. Kuba K, Kumamoto E. Long-term potentiation of transmitter release induced by adrenaline in bull-frog sympathetic ganglia. J Physiol. 1986;374:515-530.
33. Kumamoto E, Kuba K. Mechanism of long-term potentiation of transmitter release induced by adrenaline in bullfrog sympathetic ganglia. J Gen Physiol. 1986;87:775-793.
34. Scott TR, Bennett MR. The effect of nitric oxide on the efficacy of synaptic transmission through the chick ciliary ganglion. Br J Pharmacol. 1993;110:627-632.
35. Hogan YH, Hawkins R, Alkadhi KA. Adenosine A1 receptor activation inhibits LTP in sympathetic ganglia. Brain Res. 1998;807:19-28.
36. Kumamoto E, Kuba K. Sustained rise in ACh sensitivity of a sympathetic ganglion cell induced by postsynaptic electrical activities. Nature. 1983;305:145-146.
37. Kuba K, Kumamoto E. Long-term potentiations in vertebrate synapses: a variety of cascades with common subprocesses. Prog. Neurobiol. 1990;34:197-269.
38. Altememi GF, Alkadhi KA. Nitric oxide is required for the maintenance but not initiation of ganglionic long-term potentiation. Neuroscience.1999; 94:897-902.
39. Reis DJ, Ross RA, Joh TH. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse. Brain Res. 1997;136:465-474.
40. Partanen M, Waller SB, London ED, Hervonen A. Indices of neurotransmitter synthesis and release in aging sympathetic nervous system. Neurobiol Aging. 1985;6:227-232.
41. Wu RL, McKenna DG, McAfee DA. Age-related changes in the synaptic plasticity of rat superior cervical ganglia. Brain Res. 1991;542:324-329.
42. Alkadhi KA, Alzoubi KH, Aleisa AM, Nimer AS, Tanner FL. Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in sympathetic ganglia. Neurobiol. Dis. 2005;20:849-857.
43. Naftel JP, Hardy SG. Visceral motor pathways. In: Fundemental Neuroscience. Haines DE, ed. Philadelphia: Churchill-Livingstone; 1997:417-429.
44. Nauta WJT. The Frontal Granular Cortex and Behavior. Warren JW, Akert K, eds. New York: McGraw-Hill; 1964:372-396.
45. Szilagyi JE. Endogenous opiates and the pathogenesis of hypertension. Clin Exp Hypertens A. 1989;11:1-24.
46. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, DeQuattro V. Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med. 1977;296:405-411.
47. Boone JL. Stress and hypertension. Prim Care. 1991;18:623-649.
48. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
49. Kannel WB, Peter WF, Wilson MD. Cardiovascular risk factors and hypertension. In: Hypertension Primer: The Essentials of High Blood Pressure. Izzo JL, Black HR, eds. Baltimore: Lippincott Williams and Wilkens; 1999: 199-200.
50. Gerges NZ, Aleisa AM, Schwarz LA, Alkadhi KA. Chronic psychosocial stress decreases calcineurin in the dentate gyrus: a possible mechanism for preservation of early LTP. Neuroscience. 2003;117:869-874.
51. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl. 1996;14:S159-S165.
52. Siegrist J. Psychosocial factors influencing development and course of coronary heart disease. Herz. 2001;26:316-325.
53. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987;80:812-817.
54. Szilagyi JE. Psychosocial stress elevates blood pressure via an opioid dependent mechanism in normotensive rats. Clin Exp Hypertens A. 1991;13:1383-1394.
55. Skinner JE, Reed JC. Blockade of frontocortical-brain stem pathway prevents ventricular fibrillation of ischemic heart. Am J Physiol. 1981;240:H156-H163.
56. Ito H, Kanno I, Hatazawa J, Miura S. Changes in human cerebral blood flow and myocardial blood flow during mental stress measured by dual positron emission tomography. Ann Nucl Med. 2003;17:381-386.
57. Shapiro PA, Sloan RP, Bagiella E, Kuhl JP, Anjilvel S, Mann JJ. Cerebral activation, hostility, and cardiovascular control during mental stress. J Psychosom Res. 2000;48:485-491.
58. Johnston D, Wu S. Foundations of Cellular Neurophysiology. Cambridge; Mass.: MIT Press; 1995.
59. Dijkstra H, Tilders F, Smelik P. Hormonal aspecten van chronische en acute stress in hierarchische rattenkolonies. Vakbl Biol. 1985;65:387-391.
60. Sitsen JM, de Jong W. Observations on pain perception and hypertension in spontaneously hypertensive rats. Clin Exp Hypertens A. 1984;6:1345-1356.
61. Saavedra JM. Naloxone reversible decrease in pain sensitivity in young and adult spontaneously hypertensive rats. Brain Res. 1981;209:245-249.
62. Saavedra JM. Spontaneously (genetic) hypertensive rats: naloxone-reversible and propranolol-reversible decrease in pain sensitivity. Experientia. 1981;37:1002-1003.
63. Quock RM, Vaughn LK, Kouchich FJ. Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol. 1984;325:88-90.
64. Beczkowska IW, Bodnar RJ. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake. Pharmacol Biochem Behav. 1991;38:605-610.
65. Hallback M. Consequence of social isolation on blood pressure, cardiovascular reactivity and design in spontaneously hypertensive rats. Acta Physiol Scand. 1975;93:455-465.
66. Hallback M, Folkow B. Cardiovascular responses to acute mental "stress" in spontaneously hypertensive rats. Acta Physiol Scand. 1974;90:684-698.
67. Sanders BJ, Gray MJ. Early environmental influences can attenuate the blood pressure response to acute stress in borderline hypertensive rats. Physiol Behav. 1997;61:749-754.
68. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
69. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension. 1991;17:III29-III35.
70. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92:25-28.
71. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. N Engl J Med. 1996;335:1480-1485.
72. Judy WV, Watanabe AM, Henry DP, Besch HR Jr, Murphy WR, Hockel GM. Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat. Circ Res. 1976;38:21-29.
73. Bunag RD, Takeda K. Sympathetic hyperresponsiveness to hypothalamic stimulation in young hypertensive rats. Am J Physiol. 1979;237:R39-R44.
74. Koepke JP, Jones S, DiBona GF. Alpha 2-adrenoceptors in amygdala control renal sympathetic nerve activity and renal function in conscious spontaneously hypertensive rats. Brain Res. 1987;404:80-88.
75. Magee JC, Schofield GG. Neurotransmission through sympathetic ganglia of spontaneously hypertensive rats. Hypertension. 1992;20:367-373.
76. Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II. Am J Physiol. 1996;270:H275-H280.
77. Fuchs LC, Hoque AM, Clarke NL. Vascular and hemodynamic effects of behavioral stress in borderline hypertensive and Wistar-Kyoto rats. Am J Physiol. 1998;274:R375-R382.
78. Yarowsky P, Weinreich D. Loss of accommodation in sympathetic neurons from spontaneously hypertensive rats. Hypertension. 1985;7:268-276.
79. Kilpatrick GJ, Jones BJ, Tyers MB. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987;330:746-748.
80. Magee JC, Schofield GG. Alterations of synaptic transmission in sympathetic ganglia of spontaneously hypertensive rats. Am J Physiol. 1994;267:R1397-R1407.
81. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension. 1992;19:I110-I115.
82. Mancia G, Di Rienzo M, Giannattasio C, Parati G, Grassi G. Early and late sympathetic activation in hypertension. Scand Cardiovasc J Suppl. 1998;47:9-14.
83. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension. 1989;13:896-901.
84. Walker CD, Scribner KA, Stern JS, Dallman MF. Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough. Endocrinology. 1992;131:2629-2637.
85. Turner NC, Gudgeon C, Toseland N. Effects of genetic hyperinsulinaemia on vascular reactivity, blood pressure, and renal structure in the Zucker rat. J Cardiovasc Pharmacol. 1995;26:714-720.
86. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension. 1996;28:1047-1054.
87. Pacak K, Palkovits M, Makino S, Kopin IJ, Goldstein DS. Brainstem hemisection decreases corticotropin-releasing hormone mRNA in the paraventricular nucleus but not in the central amygdaloid nucleus. J Neuroendocrinol. 1996;8:543-551.
88. Pamidimukkala J, Jandhyala BS. Evaluation of hemodynamics, vascular reactivity and baroreceptor compensation in the insulin resistant Zucker obese rats. Clin Exp Hypertens. 1996;18:1089-1104.
89. Van Zwieten PA, Kam KL, Pijl AJ, Hendriks MG, Beenen OH, Pfaffendorf M. Hypertensive diabetic rats in pharmacological studies. Pharmacol Res. 1996;33:95-105.
90. Cox RH, Kikta DC. Age-related changes in thoracic aorta of obese Zucker rats. Am J Physiol. 1992;262:H1548-H1556.
91. Steinberg OH. Insulin resistance and hypertension. In: Hypertension Primer: The Essentials of High Blood Pressure. Izzo JL, Black HR, eds. New York: Lippincot Williams & Wilkins; 1999:121-122.
92. Arase K, Shargill NS, Bray GA. Effects of corticotropin releasing factor on genetically obese (fatty) rats. Physiol Behav. 1989;45:565-570.
93. Morgan DA, Anderson EA, Mark AL. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension. 1995;25:834-838.
94. Dubois EA, Kam KL, Somsen GA, Boer GJ, de Bruin K, Batink HD, Pfaffendorf M, van Royen EA, van Zwieten PA. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension. Eur J Nucl Med. 1996;23:901-908.
95. Tonello C, Giordano A, Cozzi V, Cinti S, Stock MJ, Carruba MO, Nisoli E. Role of sympathetic activity in controlling the expression of vascular endothelial growth factor in brown fat cells of lean and genetically obese rats. FEBS Lett. 1999;442:167-172.
96. Fang Z, Carlson SH, Peng N, Wyss JM. Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1490-R1495.
97. Landsberg L, Young JB. Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes. 1985;9(Suppl. 2):63-68.
98. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
99. Clapham JC, Turner NC. Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat. J Pharmacol Exp Ther. 1997;282:1503-1508.
100. Edwards E, King JA, Fray J. Hypertension and insulin resistant models have divergent propensities to learned helpless behavior in rodents. Am J Hypertens. 2000;13:659-665.
101. Walker BR, Edwards CR. New mechanisms for corticosteroid-induced hypertension. Br Med Bull. 1994;50:342-355.
102. Suter PM, Maire R, Holtz D, Vetter W. Relationship between self-perceived stress and blood pressure. J Hum Hypertens. 1997;11:171-176.
103. McCarty R. Age-related alterations in sympathetic-adrenal medullary responses to stress. Gerontology. 1986;32:172-183.
104. Porter NM, Landfield PW. Stress hormones and brain aging: adding injury to insult? Nat Neurosci. 1998;1:3-4.
105. Rodriguez-Capote K, Cespedes E, Arencibia R, Gonzalez-Hoyuela M. Indicators of oxidative stress in aging rat brain. The effect of nerve growth factor. Rev Neurol. 1998;27:494-500.
106. Butterfield DA, Howard BJ, LaFontaine MA. Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease. Curr Med Chem. 2001;8:815-828.
107. Weber MA, Neutel JM, Cheung DG. Hypertension in the aged: a pathophysiologic basis for treatment. Am J Cardiol. 1989;63:25H-32H.
108. McNeil JJ, Silagy CA. Hypertension in the elderly: epidemiology and pathophysiology. Cardiovasc Drugs Ther. 1991;6(Suppl. 4):1197-1201.
109. Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, Lambert GW, Seals DR. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation. 1995;91:351-358.
110. Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR. Aging effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278-R285.
111. Hajduczok G, Chapleau MW, Abboud FM. Increase in sympathetic activity with age, II: Role of impairment of cardiopulmonary baroreflexes. Am J Physiol. 1991;260:H1121-H1127.
112. Hajduczok G, Chapleau MW, Johnson SL, Abboud FM. Increase in sympathetic activity with age, I: Role of impairment of arterial baroreflexes. Am J Physiol. 1991;260:H1113-H1120.
113. Ng AV, Callister R, Johnson DG, Seals DR Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension. 1993;21:498-503.
114. Scarpace NT, Lowenthal DT. Sympathetic nervous system: aging and exercise. South Med J. 1994;87:S42-S46.
115. Thor PJ, Kolasinska-Kloch W, Pitala A, Janik A, Kopp B, Sibiga W. The influence of aging on autonomic nervous system activity and gastric myoelectric activity in humans. Folia Med Cracov. 1999;40:53-62.
116. Weber MA. Sympathetic nervous system and hypertension. Therapeutic perspectives. Am J Hypertens. 1989;2:147S-152S.
117. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension. 1989;13:870-877.
118. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1-S7.
119. McEwen BS. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging. 2002;23:921-939.
120. Yang GA, Koistinaho J. Age-related increase in c-fos expression in the sympathetic neurons of the rat superior cervical ganglion. Brain Res. 1990;533:338-343.
121. Schmidt RE. Age-related sympathetic ganglionic neuropathology: human pathology and animal models. Auton Neurosci. 2002;96:63-72.
122. Ferrandi M, Manunta P, Balzan S, Hamlyn JM, Bianchi G, Ferrari P. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension. 1997;30:886-896.
123. Schneider HP, Jackisch C. Potential benefits of estrogens and progestogens on breast cancer. Int J Fertil Womens Med. 1998;43:278-285.
124. Kawamura A, Guo J, Itagaki Y, Bell C, Wang Y, Haupert GT Jr, Magil S, Gallagher RT, Berova N, Nakanishi K. On the structure of endogenous ouabain. Proc Natl Acad Sci USA. 1998;96:6654-6659.
125. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, Hamlyn JM, Bianchi G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension. 1999;34:450-456.
126. Boulanger BR, Lilly MP, Hamlyn JM, Laredo J, Shurtleff D, Gann DS. Ouabain is secreted by the adrenal gland in awake dogs. Am J Physiol. 1993;264:E413-E419.
127. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology. 1994;135:794-797.
128. Hamlyn JM, Manunta P. Ouabain, digitalis-like factors and hypertension. J Hypertens Suppl. 1992;10:S99-S111.
129. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ, Pamnani MB. Longterm ouabain administration produces hypertension in rats. Hypertension. 1993;22:178-187.
130. Huang BS, Huang X, Harmsen E, Leenen FH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension. 1994;23:1087-1090.
131. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994;12:549-560.
132. Huang BS, Leenen FH. Brain "ouabain" mediates the sympathoexcitatory and hypertensive effects of high sodium intake in Dahl salt-sensitive rats. Circ Res. 1994;74:586-595.
133. Aileru AA, De Albuquerque A, Hamlyn JM, Manunta P, Shah JR, Hamilton MJ, Weinreich D. Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabaindependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2001;281:R635-R644.
134. Aileru AA, Logan E, Callahan M, Ferrario CM, Ganten D, Diz DI. Alterations in sympathetic ganglionic transmission in response to angiotensin II in (mRen2)27 transgenic rats. Hypertension. 2004 Feb;43(2):270-275.
135. Alkadhi KA, Alzoubi KH, Aleisa AM. Synaptic plasticity in sympathetic ganglia. Progress in Neurobiol. 2005;75:83-108.
136. Bachoo M, Heppner T, Fiekers J, Polosa C. A role for protein kinase C in long term potentiation of nicotinic transmission in the superior cervical ganglion of the rat. Brain Res. 1992;585:299-302.
137. Butterfield DA, Howard B, Yatin S, Koppal T, Drake J, Hensley K, Aksenov M, Aksenova M, Subramaniam R, Varadarajan S, Harris-White ME, Pedigo NW Jr, Carney JM. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci. 1999;65:1883-1892.
138. Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 2000;35:403-408.
139. Cunningham JJ, Calles-Escandon J, Garrido F, Carr DB, Bode HH. Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats. Endocrinology. 1986;118:98-101.